Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

HARDY DIAGNOSTICS

US

Last updated September 17, 2026

Information

Country
US
Address
1430 WEST MCCOY LN., Orcutt, CA, 93455
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
2022807
DUNS Number
—

Catalogue (356)

Page 5 of 8
DeviceModel / ReferenceRegistriesClassStatus
HardyCHROM G309
FDA UDI
Class IActive
HardyDisk™ Z9301
FDA UDI
Class IIActive
HardyDisk™ Z9181
FDA UDI
Class IIActive
HardyDisk™ Z8471
FDA UDI
Class IIActive
HardyDisk™ Z9395
FDA UDI
Class IIActive
StrepPRO™ PL039HD
FDA UDI
Class IActive
Nitrocef Matchbook™ Z108
FDA UDI
Class IUnknown
StaphTEX™ ST1000
FDA UDI
Class IActive
HardyDisk™ Z7501
FDA UDI
Class IActive
AlbiQuick™ Z121
FDA UDI
Class IActive
OxiStrips™ Z93
FDA UDI
Class IActive
HardyFlask™ X59
FDA UDI
Class IActive
AnaeroGRO AG22H
FDA UDI
Class IActive
HardyDisk™ Z8545
FDA UDI
Class IIActive
HardyDisk™ Z8025
FDA UDI
Class IIActive
HardyDisk™ Z9401
FDA UDI
Class IIActive
HardyDisk™ Z8371
FDA UDI
Class IIActive
AnaeroGRO AG25H
FDA UDI
Class IActive
HardyDisk™ Z9471
FDA UDI
Class IIActive
HardyDisk™ Z8815
FDA UDI
Class IIActive
HardyFlask™ X28
FDA UDI
Class IActive
HardyDisk™ Z8011
FDA UDI
Class IIActive
HardyDisk™ Z8831
FDA UDI
Class IIUnknown
HardyFlask™ X20
FDA UDI
Class IActive
HardyDisk AST Gepotidacin 10µg (GEP10) K260842
FDA 510(k)
Class IIActive
HardyDisk™ Z7121
FDA UDI
Class IActive
HardyDisk™ Z8345
FDA UDI
Class IIActive
HardyDisk™ Z8611
FDA UDI
Class IIActive
QSlide™ QS0700
FDA UDI
Class IActive
HardyDisk™ Z9121
FDA UDI
Class IIActive
HardyDisk™ Z9345
FDA UDI
Class IIActive
AnaeroGRO AG601
FDA UDI
Class IUnknown
HardyCHROM G343
FDA UDI
Class IActive
HardyDisk™ Z9441
FDA UDI
Class IIActive
QuickSlide™ GP3
FDA UDI
Class IActive
HardyDisk™ Z8411
FDA UDI
Class IActive
HardyFlask™ X19
FDA UDI
Class IActive
HardyDisk™ Z9141
FDA UDI
Class IIUnknown
HardyFlask™ X25
FDA UDI
Class IActive
SporAmpule® BST100
FDA UDI
Class IIActive
AnaeroGRO AG701
FDA UDI
Class IUnknown
GlabrataQuick™ Z298
FDA UDI
Class IActive
HardyFlask™ X30
FDA UDI
Class IActive
HardyFlask™ X26
FDA UDI
Class IActive
AnaeroGRO AG301
FDA UDI
Class IActive
TransPRO TPV50
FDA UDI
Class IActive
HardyFlask™ X10
FDA UDI
Class IActive
E. coliPRO™ PL070HD
FDA UDI
Class IActive
M. Cat Butyrate Disk K960996
FDA 510(k)
Class IActive
Hardydisk, Piperacillin/Tazobactam, 110mcg K000261
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (19)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
May 6, 2025Z-2041-2025—open, classified

Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.

Apr 16, 2021Z-1835-2021—terminated

Instruments were assembled and serviced using a defective lot of tubing, which is part of the pump mechanism within the unit.

Dec 21, 2020Z-0919-2021—terminated

Complaints were received reporting of Staphylococcus aureus (ATCC 29213) breakthrough when the strain should have been inhibited.

Oct 23, 2020Z-0655-2021—terminated

There is a potential for contamination within Viral Transport Media. Use of contaminated Viral Transport Media for the transport of patient specimen may compromise the detection of COVID-19 by the final device used for testing.

Oct 6, 2020Z-0441-2021—terminated

Streptococcus culture medium contains an incorrect expiration date. The culture medium outer box labeling contains an expiration date of 2021-11-10 instead of the correct expiration date of 2020-11-10

Nov 14, 2019Z-2298-2020—terminated

False Positive results due to the MSSA (methicillin-susceptible) strain Staphylococcus aureus (ATCC 29213) breakthrough when this strain should have been inhibited.

May 24, 2016Z-2146-2016—terminated

Discrepant culture and gram stain results, which could potentially lead to misdiagnosis or improper treatment of a patient.

Mar 21, 2016Z-1571-2016—terminated

Performance failure; poor hemolytic reaction of non or weakly hemolytic group B streptococcus (GBS) with the target QC organism, Streptococcus agalactiae (ATCC 13813) due to product deterioration.

Nov 18, 2015Z-0470-2016—terminated

The firm is recalling FB Broth Cat. no. K31, Lot no. 15231 because of potential Burkholderia fungorum contamination.

Jul 9, 2015Z-2463-2015—terminated

Hardy Diagnostics is recalling HardyCHROm MRSA due to a report of the potential for breakthrough of the methicillin-sensitive Staphylococcus aureus (MSSA) QC strain, ATCC 29213 on the identified lot.

Jun 26, 2015Z-2277-2015—terminated

Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.

Jun 26, 2015Z-2276-2015—terminated

Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.

Jun 26, 2015Z-2274-2015—terminated

Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.

Jun 26, 2015Z-2279-2015—terminated

Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.

Jun 26, 2015Z-2273-2015—terminated

Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.

Jun 26, 2015Z-2278-2015—terminated

Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.

Jun 26, 2015Z-2275-2015—terminated

Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.

Jun 24, 2015Z-2192-2015—terminated

Hardy Diagnostics is recalling HardyCHROM VRE Agar due to lack of 510(k) clearance.

Mar 4, 2015Z-1444-2015—terminated

The firm is recalling HardyCHROM SS, Cat. no. G327 Lot no. 15037 due to a report of possible lack of color development in Shigella organisms in the referenced lot.